Table 1.

Clinical characteristics observed in 8 AR mutated and in 127 non mutated KS patients.

Variable	Pt 1	Pt 2	Pt 3	Pt 4	Pt 5	Pt 6	Pt 7	Pt 8	Mean ± SD	KS with no AR mutations (127) Mean ± SD
Age (year)	18	43	41	39	34	23	50	35	35.3 ± 10.51	31.5 ± 8.5
Height (cm)	177	175	189	175	191	180	185	170	180.2 ± 7.4	181.3 ± 7.9
Weight (kg)	66	78	88	103	127	75	87	50	84.2 ± 23.3	85.4 ± 16.8
BMI (kg/m²)	21	25.4	24.6	33.6	34.7	23.1	25	17	25.5 ± 5.9	26.0 ± 4.6
Waist (cm)	84	92	96	110	124	85	101	71	95.3 ± 16.5	98.9 ± 14.9
Arm Span (cm)	180	176	190	178	194	181	186	174	182.37 ± 7.01	181.7 ± 14.3
Testicular volume L (cc)	1.7	1.5	2.8	1.5	7	1.7	1	1.1	2.28 ± 0.6	2.0 ± 0.7
Testicular volume R (cc)	1.9	2.3	3.8	2	3	1.8	1.5	1.1	2.5 ± 0.7	2.1 ± 0.8
Total Cholesterol (mg/dl) (r.v 120–200)	154	211	178	191	231	174	200	157	190.5 ± 32.2	194.8 ± 44.2
HDL (mg/dl) (r.v > 40)	62	53	59	57	32	90	51	63	59 ± 24.2	50.0 ± 15.3
Triglycerides (mg/dl) (r.v < 150)	46	112	66	101	235	40	73	38	96.5 ± 93.7	119.6 ± 163.6
Glycemia (mg/dl) (r.v 50–110)	77	92	85	80	74	88	76	77	78.7 ± 6.2	79.4 ± 13.1
Insulin (mU/l) (v.r < 29.1)	17,7	11,2	11,4	10.8	35,8	4,9	2	2	11.1 ± 16.4	9.8 ± 7.8
Total Testosterone (nmol/l) (r.v 10–29)	8.9	10.5	16.7	12.8	9.2	12.1	13.5	13.2	11.4 ± 5.17	10.5 ± 4.9
LH (IU/l) (r.v 1–9)	31.5	19.5	19.6	20.6	17.6	25.4	17.5	28.7	21.8 ± 9.4	19.6 ± 6.8
FSH (IU/l) (r.v 1–8)	85.4	33.7	34.7	35.8	19.1	39.3	23.5	62.5	36.1 ± 19.6	33.6 ± 12.9
Estradiol (pmol/l) (r.v 25–130)	51	119	156	98	94	84	103	115	99 ± 13.1	106.1 ± 34.2
PSA (g/l) (r.v < 4)	0.59	0.49	4.44	0.51	0.29	0.25	1.16	0.84	0.63 ± 0.44	0.69 ± 0.99
PTH (ng/l) (r.v. 17–73)	21.4	41.4	29	34.3	22	25.5	23	73	35.8 ± 24.7*	69.3 ± 43.2
25-hydroxyvitamin D3 (nmol/l) (r.v. 50–125)	69	68	45	49.8	30	62	58	28	51.4 ± 17.2	52.3 ± 27.3
Calcium (nmol/l) (r.v. 2.10–2.55)	2.54	2.45	2.38	2.41	2.44	2.39	2.53	2.49	2.4 ± 0.1	2.4 ± 0.1
Phosphorus (nmol/l) (r.v. 0.87–1.45)	0.84	0.8	0.8	0.81	0.8	1.05	0.65	1.11	0.91 ± 0.2	1.0 ± 0.2